MENTHOL AND METHYL SALICYLATE

MENTHOL AND METHYL SALICYLATE was reported 689 times

MENTHOL AND METHYL SALICYLATE is most commonly taken among patients reporting these side effects:

# Side effect Count Frequency
0 DEVICE STIMULATION ISSUE 1 0.0400
1 SECOND DEGREE CHEMICAL BURN OF SKIN 2 0.0333
2 BURNS FOURTH DEGREE 1 0.0323
3 BLADDER ULCER 1 0.0244
4 BASAL GANGLIA HAEMATOMA 1 0.0238
5 THIRD DEGREE CHEMICAL BURN OF SKIN 1 0.0238
6 CHEMICAL INJURY 18 0.0220
7 MASTOID EFFUSION 1 0.0200
8 BURN INFECTION 3 0.0147
9 APPLICATION SITE BURN 57 0.0116
10 BURNS SECOND DEGREE 20 0.0114
11 CHEMICAL BURN 13 0.0113
12 SINGLE COMPONENT OF A TWO-COMPONENT PRODUCT ADMINISTERED 1 0.0111
13 INTENTIONAL PRODUCT MISUSE TO CHILD 1 0.0078
14 BURNS THIRD DEGREE 8 0.0076
15 BURNS FIRST DEGREE 2 0.0070
16 BACTERIAL ABDOMINAL INFECTION 1 0.0068
17 MUCOSAL HYPERTROPHY 1 0.0068
18 ORCHIDECTOMY 1 0.0062
19 ADULT FAILURE TO THRIVE 1 0.0047
20 VERY LOW DENSITY LIPOPROTEIN INCREASED 1 0.0045
21 APPLICATION SITE HYPOAESTHESIA 1 0.0043
22 NIPPLE SWELLING 1 0.0040
23 DEVICE MAINTENANCE ISSUE 2 0.0034
24 APPLICATION SITE VESICLES 22 0.0034
25 FROSTBITE 1 0.0033
26 THERMAL BURN 21 0.0030
27 INFUSION SITE INFLAMMATION 2 0.0028
28 APPLICATION SITE PUSTULES 1 0.0027
29 CEREBRAL ARTERIOSCLEROSIS 1 0.0026
30 PRODUCT LABEL ON WRONG PRODUCT 1 0.0025
31 APPLICATION SITE SCAR 3 0.0024
32 ALVEOLAR OSTEITIS 1 0.0024
33 INFLUENZA A VIRUS TEST POSITIVE 1 0.0023
34 ALLERGY TO PLANTS 1 0.0022
35 CHONDROLYSIS 1 0.0021
36 APPLICATION SITE BRUISE 2 0.0021
37 CHEMICAL BURN OF SKIN 5 0.0020
38 APPLICATION SITE INFECTION 1 0.0020
39 KELOID SCAR 1 0.0019
40 INFUSION SITE DISCOMFORT 2 0.0019
41 APPLICATION SITE PAIN 40 0.0018
42 PRODUCT CLOSURE ISSUE 1 0.0018
43 MEDICAL DEVICE SITE PAIN 1 0.0018
44 UNINTENTIONAL USE FOR UNAPPROVED INDICATION 1 0.0017
45 APPLICATION SITE HYPERSENSITIVITY 2 0.0016
46 INFUSION SITE IRRITATION 2 0.0016
47 GINGIVAL DISCOMFORT 1 0.0015
48 SKIN DEPIGMENTATION 2 0.0015
49 TRYPTASE INCREASED 1 0.0014
50 ESCHAR 1 0.0014
51 LIMB CRUSHING INJURY 1 0.0013
52 NEGATIVISM 1 0.0013
53 INFUSION SITE PRURITUS 4 0.0013
54 POST-TRAUMATIC NECK SYNDROME 1 0.0012
55 INCISION SITE HAEMORRHAGE 1 0.0012
56 APPLICATION SITE DISCOLOURATION 5 0.0012
57 INFUSION SITE HAEMORRHAGE 4 0.0012
58 GLOMERULAR FILTRATION RATE INCREASED 1 0.0012
59 HYDROTHORAX 1 0.0012
60 INFUSION SITE OEDEMA 1 0.0012
61 GENITAL BURNING SENSATION 1 0.0012
62 THALAMUS HAEMORRHAGE 1 0.0011
63 NASAL OEDEMA 2 0.0011
64 SUSPECTED PRODUCT QUALITY ISSUE 2 0.0011
65 SKIN GRAFT 1 0.0011
66 HYPERVIGILANCE 1 0.0010
67 WOUND SECRETION 4 0.0010
68 DUST ALLERGY 1 0.0010
69 APPLICATION SITE EXFOLIATION 4 0.0010
70 PANCREATIC MASS 1 0.0009
71 APPLICATION SITE SCAB 2 0.0009
72 APPLICATION SITE ERYTHEMA 24 0.0009
73 BACTERIAL TEST POSITIVE 2 0.0009
74 SCAB 10 0.0009
75 ADMINISTRATION SITE PAIN 1 0.0009
76 HYPERTENSIVE EMERGENCY 1 0.0008
77 PRODUCT CONTAMINATION MICROBIAL 1 0.0008
78 INFUSION SITE WARMTH 1 0.0008
79 POST-ACUTE COVID-19 SYNDROME 1 0.0008
80 APPLICATION SITE SWELLING 4 0.0008
81 APPLICATION SITE WARMTH 1 0.0008
82 INFUSION SITE PAIN 10 0.0008
83 OFF LABEL USE OF DEVICE 1 0.0007
84 CHONDROPATHY 2 0.0007
85 RHONCHI 1 0.0007
86 APPLICATION SITE INFLAMMATION 1 0.0007
87 INFUSION SITE ERYTHEMA 6 0.0007
88 INFUSION SITE INDURATION 1 0.0007
89 KNEE DEFORMITY 1 0.0007
90 NO ADVERSE EVENT 120 0.0007
91 SCAR 11 0.0006
92 INFUSION SITE SWELLING 4 0.0006
93 CYSTITIS INTERSTITIAL 1 0.0006
94 HYPERAESTHESIA 5 0.0006
95 PRODUCT ADMINISTERED AT INAPPROPRIATE SITE 11 0.0006
96 TONGUE NEOPLASM MALIGNANT STAGE UNSPECIFIED 1 0.0006
97 BLISTER 33 0.0006
98 INJECTION SITE OEDEMA 1 0.0006
99 SERUM FERRITIN DECREASED 1 0.0006
100 APPLICATION SITE REACTION 4 0.0006
101 DRUG SCREEN NEGATIVE 1 0.0006
102 SCHIZOAFFECTIVE DISORDER 1 0.0006
103 DEVICE ALARM ISSUE 1 0.0006
104 ESSENTIAL HYPERTENSION 1 0.0005
105 BLOOD IRON INCREASED 1 0.0005
106 STENOSIS 1 0.0005
107 TRAUMATIC HAEMORRHAGE 1 0.0005
108 JAUNDICE NEONATAL 1 0.0005
109 JOINT NOISE 1 0.0005
110 MULTI-ORGAN DISORDER 1 0.0005
111 INTERNATIONAL NORMALISED RATIO DECREASED 2 0.0005
112 SLEEP DEFICIT 1 0.0005
113 LIMB MASS 1 0.0005
114 PRODUCT PACKAGE ASSOCIATED INJURY 1 0.0004
115 NECK SURGERY 1 0.0004
116 GASTRITIS EROSIVE 2 0.0004
117 CARTILAGE INJURY 1 0.0004
118 DEVICE INFUSION ISSUE 1 0.0004
119 BURNING SENSATION 28 0.0004
120 RADICULOPATHY 1 0.0004
121 TEMPOROMANDIBULAR JOINT SYNDROME 1 0.0004
122 BREAST SWELLING 1 0.0004
123 GINGIVITIS 2 0.0004
124 APPLICATION SITE HAEMORRHAGE 1 0.0004
125 NERVE INJURY 4 0.0004
126 DRUG TOLERANCE DECREASED 1 0.0004
127 NEUTROPHIL COUNT ABNORMAL 1 0.0004
128 FINE MOTOR SKILL DYSFUNCTION 1 0.0003
129 PULMONARY PAIN 1 0.0003
130 DEVICE POWER SOURCE ISSUE 1 0.0003
131 LUMBAR SPINAL STENOSIS 1 0.0003
132 SKIN BURNING SENSATION 24 0.0003
133 INFUSION SITE REACTION 1 0.0003
134 MYOSITIS 3 0.0003
135 CHEST X-RAY ABNORMAL 1 0.0003
136 BLOOD BLISTER 1 0.0003
137 BILE DUCT STONE 1 0.0003
138 SUSPECTED COVID-19 1 0.0003
139 PROSTATE CANCER METASTATIC 1 0.0003
140 TERMINAL STATE 2 0.0003
141 WRONG PRODUCT ADMINISTERED 2 0.0003
142 APPLICATION SITE DRYNESS 1 0.0003
143 JOINT EFFUSION 2 0.0003
144 PRODUCT ODOUR ABNORMAL 3 0.0003
145 DRUG ADMINISTERED AT INAPPROPRIATE SITE 3 0.0003
146 GLOSSITIS 1 0.0003
147 FRUSTRATION 1 0.0003
148 ASTHMATIC CRISIS 1 0.0003
149 BLOOD PHOSPHORUS DECREASED 1 0.0003
150 WOUND HAEMORRHAGE 1 0.0003
151 PARANASAL SINUS HYPERSECRETION 1 0.0003
152 SKIN ODOUR ABNORMAL 1 0.0003
153 MUSCLE HAEMORRHAGE 1 0.0002
154 ENURESIS 1 0.0002
155 FRUSTRATION TOLERANCE DECREASED 2 0.0002
156 LEG AMPUTATION 1 0.0002
157 APPLICATION SITE IRRITATION 3 0.0002
158 POOR PERIPHERAL CIRCULATION 1 0.0002
159 SHOULDER OPERATION 1 0.0002
160 MUSCLE STRAIN 2 0.0002
161 HAEMORRHAGIC ANAEMIA 1 0.0002
162 GINGIVAL SWELLING 1 0.0002
163 WHEELCHAIR USER 1 0.0002
164 BUNDLE BRANCH BLOCK RIGHT 1 0.0002
165 NEPHROPATHY 2 0.0002
166 DEVICE OCCLUSION 3 0.0002
167 SKIN ABRASION 1 0.0002
168 FINGER DEFORMITY 1 0.0002
169 DRUG EFFECTIVE FOR UNAPPROVED INDICATION 6 0.0002
170 THERAPY CHANGE 2 0.0002
171 DRUG EFFECT LESS THAN EXPECTED 3 0.0002
172 HYPERVOLAEMIA 1 0.0002
173 EXPIRED DRUG ADMINISTERED 1 0.0002
174 PRODUCT SOLUBILITY ABNORMAL 1 0.0002
175 SKIN DISCOLOURATION 9 0.0002
176 VARICOSE VEIN 1 0.0002
177 TENDERNESS 2 0.0002
178 COMPRESSION FRACTURE 1 0.0002
179 BACK INJURY 2 0.0002
180 INFECTIVE PULMONARY EXACERBATION OF CYSTIC FIBROSIS 1 0.0002
181 ASPIRATION 2 0.0002
182 TOOTH FRACTURE 2 0.0002
183 HYPERKERATOSIS 1 0.0002
184 NECK PAIN 10 0.0002
185 APPLICATION SITE PRURITUS 4 0.0002
186 VENTRICULAR SEPTAL DEFECT 1 0.0002
187 MUSCULOSKELETAL DISCOMFORT 3 0.0002
188 ENTEROCOLITIS 1 0.0002
189 SKIN WARM 1 0.0002
190 HYPERTRIGLYCERIDAEMIA 1 0.0002
191 FEELING OF BODY TEMPERATURE CHANGE 1 0.0002
192 ACCIDENT 2 0.0002
193 SKIN EXFOLIATION 14 0.0002
194 PLATELET COUNT ABNORMAL 1 0.0002
195 DERMATITIS ACNEIFORM 1 0.0002
196 CONCOMITANT DISEASE AGGRAVATED 1 0.0002
197 LIMB DISCOMFORT 5 0.0002
198 SCOLIOSIS 1 0.0002
199 CHOLANGITIS 1 0.0002
200 MULTIPLE INJURIES 1 0.0002
201 MUSCLE ATROPHY 2 0.0002
202 TENDON DISORDER 1 0.0002
203 EXPIRED PRODUCT ADMINISTERED 5 0.0002
204 SKIN DISORDER 5 0.0001
205 PAIN OF SKIN 4 0.0001
206 PRODUCT LABEL ISSUE 1 0.0001
207 ACCIDENTAL EXPOSURE TO PRODUCT BY CHILD 1 0.0001
208 APPLICATION SITE RASH 2 0.0001
209 SEASONAL ALLERGY 2 0.0001
210 PANIC REACTION 1 0.0001
211 HYPERTHYROIDISM 2 0.0001
212 BLINDNESS TRANSIENT 1 0.0001
213 SENSITIVE SKIN 1 0.0001
214 LOWER GASTROINTESTINAL HAEMORRHAGE 1 0.0001
215 DRUG INEFFECTIVE 178 0.0001
216 TENDON PAIN 1 0.0001
217 INSURANCE ISSUE 2 0.0001
218 MATERNAL DRUGS AFFECTING FOETUS 1 0.0001
219 ATRIOVENTRICULAR BLOCK 1 0.0001
220 DEVICE INFORMATION OUTPUT ISSUE 1 0.0001
221 PRODUCT ADMINISTRATION INTERRUPTED 1 0.0001
222 MUSCLE DISORDER 1 0.0001
223 BACK DISORDER 2 0.0001
224 POST PROCEDURAL INFECTION 1 0.0001
225 METASTASES TO BONE 2 0.0001
226 CANDIDA INFECTION 2 0.0001
227 INADEQUATE ANALGESIA 1 0.0001
228 ORTHOSTATIC HYPOTENSION 2 0.0001
229 MUSCULOSKELETAL PAIN 6 0.0001
230 URINE OUTPUT DECREASED 1 0.0001
231 JOINT STIFFNESS 3 0.0001
232 PRODUCT ADHESION ISSUE 4 0.0001
233 HAEMARTHROSIS 1 0.0001
234 SKIN IRRITATION 5 0.0001
235 NERVE COMPRESSION 1 0.0001
236 INCORRECT DRUG ADMINISTRATION DURATION 3 0.0001
237 SQUAMOUS CELL CARCINOMA 1 0.0001
238 SPINAL DISORDER 1 0.0001
239 RECALLED PRODUCT ADMINISTERED 1 0.0001
240 EYE INFLAMMATION 1 0.0001
241 CHOKING 2 0.0001
242 HEPATOMEGALY 1 0.0001
243 ARTHRITIS 8 0.0001
244 ACTIVITIES OF DAILY LIVING IMPAIRED 2 0.0001
245 INABILITY TO AFFORD MEDICATION 1 0.0001
246 BLOOD PRESSURE ABNORMAL 2 0.0001
247 PRODUCT PHYSICAL ISSUE 2 0.0001
248 HYPOTHERMIA 1 0.0001
249 MOTOR DYSFUNCTION 1 0.0001
250 INITIAL INSOMNIA 1 0.0001
251 ERYTHEMA 20 0.0001
252 POOR QUALITY PRODUCT ADMINISTERED 1 0.0001
253 HEAD INJURY 3 0.0001
254 CLOSTRIDIUM DIFFICILE COLITIS 1 0.0001
255 DECREASED ACTIVITY 1 0.0001
256 PHARYNGITIS STREPTOCOCCAL 1 0.0001
257 WOUND INFECTION 1 0.0001
258 ANAPHYLACTIC REACTION 5 0.0001
259 DENTAL CARIES 1 0.0001
260 RASH PAPULAR 2 0.0001
261 DERMATITIS CONTACT 1 0.0001
262 NEOPLASM 1 0.0001
263 MUSCLE RIGIDITY 1 0.0001
264 WRONG TECHNIQUE IN DRUG USAGE PROCESS 3 0.0001
265 NEURALGIA 2 0.0001
266 DISCOMFORT 5 0.0001
267 FEELING HOT 5 0.0001
268 HYPERCALCAEMIA 1 0.0001
269 EYE SWELLING 3 0.0001
270 POISONING 1 0.0001
271 LOSS OF CONSCIOUSNESS 10 0.0001
272 PERIPHERAL SWELLING 12 0.0001
273 ROTATOR CUFF SYNDROME 1 0.0001
274 HIATUS HERNIA 1 0.0001
275 INJECTION SITE INDURATION 1 0.0001
276 NODULE 1 0.0001
277 BEDRIDDEN 1 0.0001
278 BLOOD PRESSURE DECREASED 5 0.0001
279 SWELLING 7 0.0001
280 QUALITY OF LIFE DECREASED 1 0.0001
281 PRODUCT TASTE ABNORMAL 1 0.0001
282 LIMB INJURY 2 0.0001
283 PRODUCT QUALITY ISSUE 10 0.0001
284 DRUG TOXICITY 1 0.0001
285 ROAD TRAFFIC ACCIDENT 3 0.0001
286 HAEMOPTYSIS 2 0.0001
287 PAIN 44 0.0001
288 WOUND 2 0.0001
289 MASS 1 0.0001
290 PAIN IN EXTREMITY 21 0.0001
291 EYE PAIN 4 0.0001
292 HYPERSENSITIVITY 13 0.0001
293 DYSPHONIA 4 0.0001
294 NASAL CONGESTION 4 0.0001
295 SKIN HAEMORRHAGE 1 0.0001
296 PULMONARY MASS 1 0.0001
297 HAEMORRHAGE INTRACRANIAL 1 0.0001
298 HYPOAESTHESIA 10 0.0001
299 ECONOMIC PROBLEM 1 0.0001
300 BLOOD COUNT ABNORMAL 1 0.0001
301 DEVICE FAILURE 1 0.0001
302 DEVICE ADHESION ISSUE 1 0.0001
303 PHARYNGEAL OEDEMA 1 0.0001
304 MUSCULOSKELETAL CHEST PAIN 1 0.0001
305 ANKLE FRACTURE 1 0.0001
306 TENDONITIS 1 0.0001
307 BACK PAIN 15 0.0001
308 THERAPY PARTIAL RESPONDER 1 0.0001
309 CYANOSIS 1 0.0001
310 PRODUCTIVE COUGH 3 0.0001
311 MOVEMENT DISORDER 2 0.0001
312 MUSCLE TIGHTNESS 1 0.0001
313 AMNESIA 4 0.0001
314 IMPAIRED HEALING 2 0.0001
315 COAGULOPATHY 1 0.0001
316 MUSCLE SPASMS 11 0.0001
317 URINARY RETENTION 2 0.0001
318 PERICARDITIS 1 0.0001
319 HEMIPARESIS 1 0.0001
320 FLUID RETENTION 3 0.0001
321 CIRCULATORY COLLAPSE 1 0.0001
322 PRODUCT USE ISSUE 11 0.0001
323 LOCAL SWELLING 1 0.0001
324 INJURY 4 0.0001
325 DEPRESSED MOOD 3 0.0001
326 BLOOD TRIGLYCERIDES INCREASED 1 0.0001
327 HEAD DISCOMFORT 1 0.0001
328 THERAPEUTIC PRODUCT EFFECT INCOMPLETE 4 0.0001
329 GALLBLADDER DISORDER 1 0.0001
330 INCORRECT ROUTE OF DRUG ADMINISTRATION 2 0.0001
331 MOBILITY DECREASED 4 0.0001
332 ARTHRALGIA 23 0.0001
333 TOOTHACHE 1 0.0001
334 OSTEOMYELITIS 1 0.0001
335 PELVIC PAIN 1 0.0001
336 BRONCHITIS 4 0.0001
337 CONJUNCTIVITIS 1 0.0001
338 MIDDLE INSOMNIA 1 0.0001
339 URINARY TRACT INFECTION 9 0.0001
340 GASTRIC ULCER 1 0.0001
341 INCREASED APPETITE 1 0.0001
342 GAIT DISTURBANCE 10 0.0001
343 POST PROCEDURAL COMPLICATION 1 0.0001
344 LOWER LIMB FRACTURE 1 0.0001
345 CONTUSION 5 0.0001
346 PRESCRIBED OVERDOSE 1 0.0001
347 DYSTONIA 1 0.0001
348 EAR PAIN 1 0.0001
349 BONE PAIN 3 0.0001
350 DISABILITY 1 0.0001
351 SINUS DISORDER 1 0.0001
352 THERAPEUTIC RESPONSE DECREASED 3 0.0000
353 INSOMNIA 13 0.0000
354 PULMONARY HYPERTENSION 1 0.0000
355 DERMATITIS 1 0.0000
356 POOR QUALITY SLEEP 1 0.0000
357 DEEP VEIN THROMBOSIS 3 0.0000
358 INCORRECT PRODUCT ADMINISTRATION DURATION 1 0.0000
359 DEVICE DISLOCATION 2 0.0000
360 CONSTIPATION 10 0.0000
361 INTERVERTEBRAL DISC PROTRUSION 1 0.0000
362 MUSCULOSKELETAL STIFFNESS 4 0.0000
363 RASH MACULO-PAPULAR 1 0.0000
364 NEOPLASM MALIGNANT 3 0.0000
365 GLOSSODYNIA 1 0.0000
366 THERAPEUTIC PRODUCT EFFECT DECREASED 2 0.0000
367 DEVICE ISSUE 4 0.0000
368 THERAPEUTIC RESPONSE UNEXPECTED 2 0.0000
369 THERAPY NON-RESPONDER 2 0.0000
370 CHROMATURIA 1 0.0000
371 PERICARDIAL EFFUSION 1 0.0000
372 INAPPROPRIATE SCHEDULE OF DRUG ADMINISTRATION 3 0.0000
373 NEUROPATHY PERIPHERAL 4 0.0000
374 RASH ERYTHEMATOUS 2 0.0000
375 BLOOD PRESSURE FLUCTUATION 1 0.0000
376 LOSS OF PERSONAL INDEPENDENCE IN DAILY ACTIVITIES 2 0.0000
377 PRURITUS 16 0.0000
378 INFECTION 6 0.0000
379 OEDEMA PERIPHERAL 5 0.0000
380 LUNG DISORDER 2 0.0000
381 INJECTION SITE URTICARIA 1 0.0000
382 ABASIA 1 0.0000
383 DYSGEUSIA 3 0.0000
384 CELLULITIS 2 0.0000
385 THERAPY CESSATION 2 0.0000
386 INFLAMMATION 2 0.0000
387 SKIN ULCER 1 0.0000
388 RESPIRATORY TRACT INFECTION 1 0.0000
389 DEAFNESS 1 0.0000
390 SPEECH DISORDER 2 0.0000
391 INJECTION SITE BRUISING 3 0.0000
392 INJECTION SITE HAEMORRHAGE 3 0.0000
393 OEDEMA 2 0.0000
394 DRUG INEFFECTIVE FOR UNAPPROVED INDICATION 2 0.0000
395 FALL 12 0.0000
396 ARTHROPATHY 2 0.0000
397 MEDICATION ERROR 2 0.0000
398 PAIN IN JAW 1 0.0000
399 MYALGIA 6 0.0000
400 FLATULENCE 2 0.0000
401 INTENTIONAL DOSE OMISSION 1 0.0000
402 HYPERSOMNIA 1 0.0000
403 HERPES ZOSTER 2 0.0000
404 DECREASED APPETITE 8 0.0000
405 INTENTIONAL PRODUCT MISUSE 3 0.0000
406 URINARY INCONTINENCE 1 0.0000
407 RESPIRATORY DISORDER 1 0.0000
408 INAPPROPRIATE SCHEDULE OF PRODUCT ADMINISTRATION 6 0.0000
409 BLOOD POTASSIUM DECREASED 1 0.0000
410 JOINT SWELLING 4 0.0000
411 EPILEPSY 1 0.0000
412 CARDIAC DISORDER 3 0.0000
413 SWOLLEN TONGUE 1 0.0000
414 DYSPNOEA 18 0.0000
415 CYSTITIS 1 0.0000
416 WEIGHT INCREASED 7 0.0000
417 NIGHT SWEATS 1 0.0000
418 RHINORRHOEA 2 0.0000
419 PRODUCT DOSE OMISSION 2 0.0000
420 PSORIASIS 4 0.0000
421 EYE DISORDER 1 0.0000
422 HEADACHE 19 0.0000
423 ABDOMINAL PAIN 7 0.0000
424 LIP SWELLING 1 0.0000
425 GAIT INABILITY 1 0.0000
426 HYPOTENSION 6 0.0000
427 URTICARIA 5 0.0000
428 ABDOMINAL DISCOMFORT 5 0.0000
429 SOMNOLENCE 6 0.0000
430 VOMITING 14 0.0000
431 TRANSIENT ISCHAEMIC ATTACK 1 0.0000
432 CHEST DISCOMFORT 3 0.0000
433 FEELING ABNORMAL 7 0.0000
434 ILLNESS 3 0.0000
435 RASH MACULAR 1 0.0000
436 LYMPHADENOPATHY 1 0.0000
437 SYSTEMIC LUPUS ERYTHEMATOSUS 1 0.0000
438 CEREBRAL HAEMORRHAGE 1 0.0000
439 DRUG EFFECT INCOMPLETE 1 0.0000
440 CRYING 1 0.0000
441 PANIC ATTACK 1 0.0000
442 UNDERDOSE 2 0.0000
443 INJECTION SITE MASS 1 0.0000
444 SEPSIS 3 0.0000
445 DYSPNOEA EXERTIONAL 1 0.0000
446 ASTHMA 3 0.0000
447 RHEUMATOID ARTHRITIS 3 0.0000
448 MUSCULAR WEAKNESS 3 0.0000
449 DIARRHOEA 17 0.0000
450 CHRONIC KIDNEY DISEASE 2 0.0000
451 BLOOD PRESSURE INCREASED 4 0.0000
452 DIZZINESS 13 0.0000
453 PLASMA CELL MYELOMA 1 0.0000
454 CHILLS 3 0.0000
455 PARAESTHESIA 4 0.0000
456 ABNORMAL BEHAVIOUR 1 0.0000
457 DISORIENTATION 1 0.0000
458 CARDIAC FAILURE CONGESTIVE 2 0.0000
459 DRY MOUTH 2 0.0000
460 PSORIATIC ARTHROPATHY 1 0.0000
461 FATIGUE 19 0.0000
462 OSTEOPOROSIS 1 0.0000
463 NAUSEA 19 0.0000
464 RHABDOMYOLYSIS 1 0.0000
465 POLLAKIURIA 1 0.0000
466 RENAL IMPAIRMENT 2 0.0000
467 RENAL FAILURE ACUTE 1 0.0000
468 HYPOACUSIS 1 0.0000
469 PYREXIA 8 0.0000
470 RASH 10 0.0000
471 COVID-19 4 0.0000
472 TACHYCARDIA 2 0.0000
473 ADVERSE DRUG REACTION 2 0.0000
474 VISION BLURRED 3 0.0000
475 MEMORY IMPAIRMENT 3 0.0000
476 NEPHROLITHIASIS 1 0.0000
477 ADVERSE EVENT 2 0.0000
478 NASOPHARYNGITIS 4 0.0000
479 HYPOKALAEMIA 1 0.0000
480 RENAL DISORDER 1 0.0000
481 COGNITIVE DISORDER 1 0.0000
482 OCULAR HYPERAEMIA 1 0.0000
483 PULMONARY EMBOLISM 2 0.0000
484 MIGRAINE 2 0.0000
485 MULTIPLE SCLEROSIS 1 0.0000
486 HEART RATE INCREASED 2 0.0000
487 PRODUCT USE IN UNAPPROVED INDICATION 5 0.0000
488 DRY EYE 1 0.0000
489 WRONG TECHNIQUE IN PRODUCT USAGE PROCESS 4 0.0000
490 SINUSITIS 2 0.0000
491 ACCIDENTAL EXPOSURE TO PRODUCT 2 0.0000
492 HAEMORRHAGE 2 0.0000
493 ECZEMA 1 0.0000
494 PANCREATITIS 1 0.0000
495 BRADYCARDIA 1 0.0000
496 DRUG DEPENDENCE 3 0.0000
497 ASTHENIA 7 0.0000
498 PNEUMONIA 6 0.0000
499 RASH PRURITIC 1 0.0000
500 MALAISE 8 0.0000
501 HAEMATOCHEZIA 1 0.0000
502 TREMOR 3 0.0000
503 DEPRESSION 4 0.0000
504 LETHARGY 1 0.0000
505 PRODUCT SUBSTITUTION ISSUE 1 0.0000
506 SEIZURE 2 0.0000
507 MYOCARDIAL INFARCTION 3 0.0000
508 PALPITATIONS 2 0.0000
509 SURGERY 1 0.0000
510 WHEEZING 1 0.0000
511 CATARACT 1 0.0000
512 IRRITABILITY 1 0.0000
513 CONDITION AGGRAVATED 5 0.0000
514 CHEST PAIN 3 0.0000
515 INJECTION SITE ERYTHEMA 2 0.0000
516 EXPOSURE DURING PREGNANCY 1 0.0000
517 INTENTIONAL OVERDOSE 1 0.0000
518 SWELLING FACE 1 0.0000
519 DEVICE DIFFICULT TO USE 1 0.0000
520 COUGH 4 0.0000
521 SLEEP DISORDER 1 0.0000
522 ANXIETY 4 0.0000
523 EPISTAXIS 1 0.0000
524 HALLUCINATION 1 0.0000
525 HOT FLUSH 1 0.0000
526 UNEVALUABLE EVENT 1 0.0000
527 INJECTION SITE SWELLING 1 0.0000
528 HOSPITALISATION 2 0.0000
529 DRUG INTERACTION 2 0.0000
530 THROMBOSIS 1 0.0000
531 GASTROOESOPHAGEAL REFLUX DISEASE 1 0.0000
532 CONFUSIONAL STATE 2 0.0000
533 INFLUENZA LIKE ILLNESS 1 0.0000
534 DRUG DOSE OMISSION 2 0.0000
535 TOXICITY TO VARIOUS AGENTS 2 0.0000
536 BALANCE DISORDER 1 0.0000
537 DRUG WITHDRAWAL SYNDROME 1 0.0000
538 GASTROINTESTINAL DISORDER 1 0.0000
539 OROPHARYNGEAL PAIN 1 0.0000
540 WEIGHT DECREASED 3 0.0000
541 DYSPHAGIA 1 0.0000
542 ATRIAL FIBRILLATION 1 0.0000
543 ALOPECIA 2 0.0000
544 DYSPEPSIA 1 0.0000
545 SYNCOPE 1 0.0000
546 INJECTION SITE PAIN 3 0.0000
547 MALIGNANT NEOPLASM PROGRESSION 1 0.0000
548 ABDOMINAL PAIN UPPER 2 0.0000
549 ABDOMINAL DISTENSION 1 0.0000
550 OFF LABEL USE 8 0.0000
551 DISEASE PROGRESSION 1 0.0000
552 EMOTIONAL DISTRESS 1 0.0000
553 DEATH 7 0.0000
554 VISUAL IMPAIRMENT 1 0.0000
555 HYPERHIDROSIS 1 0.0000
556 DRY SKIN 1 0.0000
557 PRODUCT DOSE OMISSION ISSUE 2 0.0000
558 CEREBROVASCULAR ACCIDENT 1 0.0000
559 INCORRECT DOSE ADMINISTERED 1 0.0000